Wilson's Disease Treatment Agents

Wilson's disease treatment agents are a therapeutic group of medications indicated for the management of Wilson's disease, a rare autosomal recessive genetic disorder characterized by impaired biliary excretion and toxic systemic accumulation of copper Rather than functioning through a single pathway, this therapeutic class encompasses systemic copper-chelating agents, such as penicillamine and trientine salts, which bind circulating copper to promote its renal excretion, as well as oral zinc fo...

Wilson's disease treatment agents are a therapeutic group of medications indicated for the management of Wilson's disease, a rare autosomal recessive genetic disorder characterized by impaired biliary excretion and toxic systemic accumulation of copper Together, these agents serve to deplete toxic tissue copper stores and prevent re-accumulation, thereby mitigating progressive hepatic, neurologic, and psychiatric complications

Wilson's disease treatment agents are a therapeutic group of medications indicated for the management of Wilson's disease, a rare autosomal recessive genetic disorder characterized by impaired biliary excretion and toxic systemic accumulation of copper Together, these agents serve to deplete toxic tissue copper stores and prevent re-accumulation, thereby mitigating progressive hepatic, neurologic, and psychiatric complications

Rather than functioning through a single pathway, this therapeutic class encompasses systemic copper-chelating agents, such as penicillamine and trientine salts, which bind circulating copper to promote its renal excretion, as well as oral zinc formulations that induce intestinal metallothionein to block gastrointestinal copper absorption

Rather than functioning through a single pathway, this therapeutic class encompasses systemic copper-chelating agents, such as penicillamine and trientine salts, which bind circulating copper to promote its renal excretion, as well as oral zinc formulations that induce intestinal metallothionein to block gastrointestinal copper absorption